Next Generation Biotics
Next Generation Prebiotics, postbiotics and probiotics for indication specific beneficial effects.
ACARYON
25 years of Next-Generation Biotics expertise
From discovery to market launch, ACARYON brings proven expertise across every stage of development: bench research, regulatory strategy, industrial production, clinical trials, and commercialization.
NEXT GENRATION BIOTICS
At ACARYON, we specialize in the development of indication-specific Next-Generation Biotics.
Unlike conventional biotics, Next-Generation Biotics are designed with a defined mode of action and a clear, indication-specific benefit.
Whether you want to develop a strain from scratch or screen your existing strain bank for targeted functional properties, ACARYON provides the scientific platform and expertise to accelerate development.
MicroSIS
MicroSIS (Microorganism-Specific Isolation and Selection) is ACARYON’s proprietary platform for the direct selection and isolation of microorganisms with targeted functional properties, either from the microbiome or from your own strain bank.
Identify and isolate microorganisms with specific, desired functions
Screen strain banks for targeted microbiome modulation properties
Accelerate the development of differentiated Next-Generation Biotics
With MicroSIS, you can:
Combined with HUMIPLATE, MicroSIS offers:
A unique platform to identify microorganisms with specific microbiome-modulating properties
A powerful solution for selecting strains based on biologically relevant functional effects
New opportunities to develop highly targeted Next-Generation Biotic
Microbial Carbohydrates: A Key Lever for Next-Generation Biotics
Microbial carbohydrates and carbohydrate-binding structures are deeply involved in:
Regulation of microbiome composition
Development and regulation of the immune system
Regulation of metabolic processes
And much more.
Application Examples
Selected bacetrial strains carrying defined carbohydrate antigens may help in controling infections, as many pathogens and their toxins rely on carbohydrate–protein interactions to bind to host cells.
Anti-infection
Immune Activation
Selected bacterial strains carrying defined carbohydrate antigens may help induce highly specific immune responses, creating new possibilities in cancer therapy, infection prevention, and immune modulation.
Chronic Diseases
Another promising avenue is targeted delivery: bacteria expressing specific carbohydrate or carbohydrate-binding structures could be designed to recognize altered surface glycans on inflamed or cancerous tissues and act locally at the desired site.
